Richard D. Truesdell, Jr.

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by AbbVie Inc. of $6 billion aggregate principal amount of senior notes in four…

Davis Polk advised the representatives of the several underwriters in connection with Galapagos NV’s offering of 2,961,373 ordinary shares in the form of American depositary shares, which…

Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $20 billion in aggregate principal amount of senior notes by Halfmoon Parent,…

Davis Polk advised the joint book-running managers in connection with the $129.2 million SEC-registered follow-on offering of 2,880,979 shares of Class A common stock of Hamilton Lane…

Davis Polk advised Zai Lab Limited in connection with its first follow-on offering of $150 million of American Depositary Shares representing 7,500,000 ordinary shares of the company. The…

Davis Polk advised the joint book-runners and representatives of the underwriters on an SEC-registered offering by Fluor Corporation of $600 million aggregate principal amount of its 4…

Davis Polk is advising Tyson Foods, Inc. on its $2.16 billion acquisition of the Keystone Foods business from Marfrig Global Foods. The transaction, which is expected to close in mid-fiscal…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Zoetis Inc. of $300 million aggregate principal amount of its floating-rate senior notes…

Davis Polk advised the representatives of the underwriters in connection with the $175.5 million offering of 2,700,000 shares of common stock of REGENXBIO Inc. The common stock is listed on…

Davis Polk advised the representatives of the underwriters in connection with the $615.4 million initial public offering of 18,648,649 shares of Class A common stock of Focus Financial…